Ventripoint Diagnostics Ltd. (TSXV:VPT)

Market Cap	17.97M
Revenue (ttm)	166.49K
Net Income (ttm)	-4.69M
Shares Out	163.38M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	298,075
Average Volume	102,884
Open	0.1050
Previous Close	0.1100
Day's Range	0.1000 - 0.1100
52-Week Range	0.0750 - 0.2450
Beta	0.27
RSI	40.89
Earnings Date	Jun 5, 2025

About Ventripoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, in...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Hugh MacNaught
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VPT

Financial Performance

In 2024, Ventripoint Diagnostics's revenue was 95,172, an increase of 93.51% compared to the previous year's 49,183. Losses were -4.92 million, 0.98% more than in 2023.